ÂÜÀòÂÒÂ×

Julie Meyer has significant work experience in the field of strategic business development and pharmaceutical partnering, with a particular focus on oncology diagnostics and next-generation sequencing products. Julie currently works as the Director of Strategic Business Development at Personalis, Inc., where they identify and develops programs within the pharmaceutical industry that would benefit from design-controlled, regulatory-approved, NGS diagnostics. Prior to this, Julie served as the Director of Pharma CDx Business Development at ArcherDX, Inc. from 2020 to 2021. From 2016 to 2020, they held the position of Manager of Pharma Partnering at Personal Genome Diagnostics, where they closed genomic profiling deals and secured strategic partnerships for a portfolio of kit-based in vitro diagnostic products. Before that, Julie worked as a Senior Strategic Account Manager at QIAGEN from 2004 to 2015, managing multi-million dollar territories and delivering revenue growth. Julie began their career as a Research Technologist at the Roswell Park Cancer Institute from 2002 to 2004.

Julie Meyer attended the University of Rochester from 1998 to 2002, where they earned dual Bachelor's degrees in Biology and Psychology. Julie is currently enrolled in the HMX Fundamentals/Pro online certificate program at Harvard Medical School, focusing on Immunology and Immuno-oncology.